POSA128 Cost-Effectiveness Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as a First-Line (1L) Maintenance Treatment for Patients With Locally Advanced or Metastatic Urothelial Carcinoma in Taiwan.
In: Value in Health, Jg. 25 (2022-01-02), Heft 1, S. S58- (2S.)
Online
academicJournal
Zugriff:
Titel: |
POSA128 Cost-Effectiveness Analysis of Avelumab Plus Best Supportive Care (BSC) vs BSC Alone as a First-Line (1L) Maintenance Treatment for Patients With Locally Advanced or Metastatic Urothelial Carcinoma in Taiwan.
|
---|---|
Autor/in / Beteiligte Person: | Chang, WC ; Xiao, Y ; Lin, AY ; Su, PJ ; Goh, C ; Wu, E ; Liu, K ; Chou, P ; Kuo, K ; Palencia, R ; Chang, J ; Kearney, M ; Kapetanakis, V ; Benedict, Á |
Link: | |
Zeitschrift: | Value in Health, Jg. 25 (2022-01-02), Heft 1, S. S58- (2S.) |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1098-3015 (print) |
DOI: | 10.1016/j.jval.2021.11.271 |
Schlagwort: |
|
Sonstiges: |
|